£107.98

Springer Resistance to Tyrosine Kinase Inhibitors (Resistance to Targeted Anti-Cancer Therapeutics)

Price data checked 1 day ago

View at Amazon

We'll watch every seller, every day. One email when your price arrives.

It has never been this cheap. We have no record of a lower price.

£108 today · cheaper than every other day in the last 3 months

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey
↓ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 90 days • 90 data points

Historical
Generating forecast...
£113.76 £107.40 £108.79 £110.18 £111.56 £112.95 £114.34 18 February 2026 12 March 2026 03 April 2026 25 April 2026 18 May 2026

Price Distribution

Price distribution over 90 days • 3 price levels

Days at Price
Current Price
5 days · current 70 days 15 days 0 18 35 53 70 £108 £113 £114 Days at Price

Price Analysis

Most common price: £113 (70 days, 77.8%)

Price range: £108 - £114

Price levels: 3 different prices over 90 days

Description

The volume will serve as a primer on tyrosine kinase signaling and its importance in cancer. The volume will first introduce the common denominators of small-molecule and antibody-derived inhibitors, as well as the general phenomenon of resistance. The volume will then detail resistance to the most commonly used classes of tyrosine kinase inhibitors, and will focus specific chapters on resistance to BCR-ABL1, FLT3, angiokinase family members, and ALK inhibitors.

Product Specifications

Barcode

No barcode data available

Similar Products You Might Like

Resistance to Anti-Cancer Therapeutics Targeting Receptor Tyrosine Kinases and Downstream Pathways: 15
85% match

Resistance to Anti-Cancer Therapeutics Targeting Receptor Tyrosine Kinases and Downstream Pathways: 15

Springer

£109.85 18 May 2026
Molecular Oncology: Underlying Mechanisms and Translational Advancements
84% match

Molecular Oncology: Underlying Mechanisms and Translational Advancements

Springer

£80.64 17 May 2026
Resistance to Targeted Therapies in Breast Cancer: 16 (Resistance to Targeted Anti-Cancer Therapeutics, 16)
84% match

Resistance to Targeted Therapies in Breast Cancer: 16 (Resistance to Targeted Anti-Cancer Therapeutics, 16)

Springer

£79.97 18 May 2026
Cancer Genetics and Therapeutics: Focus on Phytochemicals
83% match

Cancer Genetics and Therapeutics: Focus on Phytochemicals

Springer

£74.27 18 May 2026
General Principles of Tumor Immunotherapy: Basic and Clinical Applications of Tumor Immunology
83% match

General Principles of Tumor Immunotherapy: Basic and Clinical Applications of Tumor Immunology

Springer

£147.83 11 May 2026
Advances and Prospects of 3-d Metal-Based Anticancer Drug Candidates
82% match

Advances and Prospects of 3-d Metal-Based Anticancer Drug Candidates

Springer

£141.86 14 May 2026
Cancer Immunotherapy: Paradigms, Practice and Promise
82% match

Cancer Immunotherapy: Paradigms, Practice and Promise

Springer

£108.92 18 May 2026
Cell Signaling & Molecular Targets in Cancer
82% match

Cell Signaling & Molecular Targets in Cancer

Springer

£107.98 14 May 2026
Cell Signaling & Molecular Targets in Cancer
82% match

Cell Signaling & Molecular Targets in Cancer

Springer

£43.99 04 May 2026
Targeting the Wnt Pathway in Cancer
82% match

Targeting the Wnt Pathway in Cancer

Springer

£107.98 18 May 2026
Resistance to Molecular Therapies for Hepatocellular Carcinoma: 13 (Resistance to Targeted Anti-Cancer Therapeutics)
82% match

Resistance to Molecular Therapies for Hepatocellular Carcinoma: 13 (Resistance to Targeted Anti-Cancer Therapeutics)

Springer

£107.30 18 May 2026
Advances in Tumor Immunology and Immunotherapy (Current Cancer Research)
82% match

Advances in Tumor Immunology and Immunotherapy (Current Cancer Research)

Springer

£111.48 18 May 2026
Drug Resistance in Cancer Therapy: 48 (Cancer Treatment and Research, 48)
82% match

Drug Resistance in Cancer Therapy: 48 (Cancer Treatment and Research, 48)

Springer

£113.76 18 May 2026
Cytokine and Chemokine Networks in Cancer
82% match

Cytokine and Chemokine Networks in Cancer

Springer

£142.07 18 May 2026
Pathobiology of Cancer Regimen-Related Toxicities
82% match

Pathobiology of Cancer Regimen-Related Toxicities

Springer

£107.98 18 May 2026
Nutraceuticals and Cancer
82% match

Nutraceuticals and Cancer

Springer

£113.76 18 May 2026
Gene-Based Therapies for Cancer (Current Cancer Research)
81% match

Gene-Based Therapies for Cancer (Current Cancer Research)

Springer

£107.50 18 May 2026
Molecular Pathogenesis of Colorectal Cancer
81% match

Molecular Pathogenesis of Colorectal Cancer

Springer

£110.54 18 May 2026
Angiogenesis and Anti-Angiogenesis in Hematological Malignancies
81% match

Angiogenesis and Anti-Angiogenesis in Hematological Malignancies

Springer

£76.24 18 May 2026
Cancer Chemotherapy: Concepts, Clinical Investigations and Therapeutic Advances: 42 (Cancer Treatment and Research, 42)
81% match

Cancer Chemotherapy: Concepts, Clinical Investigations and Therapeutic Advances: 42 (Cancer Treatment and Research, 42)

Springer

£107.85 18 May 2026
Practical Management of Thyroid Cancer: A Multidisciplinary Approach
81% match

Practical Management of Thyroid Cancer: A Multidisciplinary Approach

Springer

£88.17 16 May 2026
Cytokines and Cancer: 126 (Cancer Treatment and Research, 126)
81% match

Cytokines and Cancer: 126 (Cancer Treatment and Research, 126)

Springer

£113.76 18 May 2026
Targeting the DNA Damage Response for Cancer Therapy: 186 (Cancer Treatment and Research, 186)
81% match

Targeting the DNA Damage Response for Cancer Therapy: 186 (Cancer Treatment and Research, 186)

Springer

£73.10 15 May 2026
Bioactive Essential Oils and Cancer
81% match

Bioactive Essential Oils and Cancer

Springer

£107.98 19 May 2026